BWX Technologies (BWXT) Earnings Date & Reports

Key Takeaways

• Third quarter 2026 revenue rose 10% year over year to $953 million, but came in slightly below the consensus estimate of roughly $973 million.
• Adjusted earnings per share (EPS, or profit divided by shares outstanding) reached $1.26, beating the $1.19 consensus estimate by about 5.7% and rising 26% from a year ago.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) grew 19% to $179.7 million, with an 18.9% margin that expanded 150 basis points.
• Free cash flow jumped 59% to $151 million, while total backlog climbed 15.6% to $8.56 billion.
• Management tightened full-year 2026 guidance to adjusted EPS of $4.72 to $4.77 and raised the low end of its free cash flow outlook to $350 million to $360 million.
• Despite the bottom-line beat, shares slipped roughly 2.7% in after-hours trading as investors weighed the top-line shortfall.
• For more on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the additional pages linked here for deeper analysis.
• Explore Trending AI Robots to see how AI-driven trading strategies are approaching opportunities across the market.

Earnings Context and Why It Matters

BWX Technologies (BWXT) occupies a unique position at the intersection of national security and the commercial nuclear power resurgence. The company supplies nuclear components and fuel for U.S. Navy propulsion programs while also serving civilian reactor operators, nuclear medicine, and advanced microreactor developers. With demand strengthening across both government and commercial segments, each quarterly report offers a gauge of how quickly that demand is converting into firm awards and revenue. Investors also track margin execution closely, since BWXT has been expanding manufacturing capacity ahead of an anticipated surge in orders. The third quarter mattered because it tested whether the company could maintain profitability gains even as top-line growth trailed some expectations.

Reported Results

For the third quarter of 2026, BWX Technologies reported revenue of $953 million, up 10% year over year, including 7% organic growth. The result fell slightly short of the roughly $973 million Wall Street consensus. Government Operations revenue increased 4% to $639 million, driven by Special Materials and Advanced Nuclear programs, while Commercial Operations revenue rose 25% to $314 million, aided by the Precision Components Group acquisition.

Adjusted EPS came in at $1.26, exceeding the $1.19 consensus estimate and up 26% from $1.00 in the prior-year period. Adjusted EBITDA increased 19% to $179.7 million, above the $167.5 million consensus, reflecting an 18.9% margin. Free cash flow reached $151 million, up from $95 million a year earlier. Management reaffirmed full-year revenue guidance of approximately $3.8 billion and adjusted EPS of $4.72 to $4.77, while raising the low end of its free cash flow range to $350 million to $360 million.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening. Whether you are monitoring earnings movers like BWXT or scanning for emerging setups, the AI Screener provides a structured way to focus your research on the ideas that matter most.

Market Reaction and Investor Sentiment

The market's response to BWXT's report was mixed, underscoring how elevated expectations can outweigh strong bottom-line execution. Shares fell about 2.7% in after-hours trading to around $127, despite an earnings beat and margin expansion. The decline suggests investors were focused on the modest revenue miss and the pace at which a robust bid pipeline is converting into firm awards. Trading near the lower end of a 52-week range of $123.05 to $241.82, the stock reflects a cautious sentiment environment in which even solid profitability gains leave limited room for disappointment. Investors appeared to reward the company's cash generation and guidance consistency, but the top-line shortfall remained the dominant narrative heading into the next trading session.

Forward Outlook and Key Factors to Monitor

Looking ahead, BWXT provided a preliminary 2027 outlook calling for high single-digit to low double-digit growth in adjusted EBITDA and adjusted EPS, supported by its core businesses and expanding Special Materials contributions. For the remainder of 2026, the company continues to expect revenue of approximately $3.8 billion, adjusted EBITDA of about $667 million, and adjusted EPS between $4.72 and $4.77.

Several factors will shape the next chapter. First, investors should watch the conversion of BWXT's growing bid pipeline into firm contracts, particularly in naval propulsion and advanced nuclear programs such as the BANR microreactor, which was recently selected for U.S. Army and Canadian projects. Second, capacity investments are a key watch item, as the company expands facilities in Cambridge, Ontario, and evaluates a new U.S. commercial manufacturing plant. Third, the integration of the Precision Components Group acquisition and the planned medical business divestiture could influence segment growth and margins.

Finally, capital allocation and balance sheet strength remain important. Following an inaugural investment-grade credit rating from Fitch, BWXT has signaled disciplined priorities centered on organic growth, selective acquisitions, and shareholder returns. While the demand backdrop for nuclear energy and national security remains supportive, the timing of large awards and execution across multiple ramping programs will be central to whether the company sustains its momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations